The association between HLA and non-Hodgkin lymphoma subtypes, among a transplant-indicated population

References

• Johnson PCD, McAulay KA, Montgomery D, et al. Modeling HLA associations with EBV-positive and -negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis. Int J Cancer. 2015;137:1066–1075.
   PubMed Web of Science ®Google Scholar
• McAulay KA, Jarrett RF. Human leukocyte antigens and genetic susceptibility to lymphoma. Tissue Antigens. 2015;86:98–113.
   PubMedGoogle Scholar
• Wang SS, Lu Y, Rothman N, et al. Variation in effects of non-Hodgkin lymphoma risk factors according to the human leukocyte antigen (HLA)-DRB1*01:01 allele and ancestral haplotype 8.1. PLoS ONE. 2011;6:e26949.
   PubMed Web of Science ®Google Scholar
• Riemersma SA, Jordanova ES, Haasnoot GW, et al. The relationship between HLA class II polymorphisms and somatic deletions in testicular B cell lymphomas of Dutch patients. Hum Immunol. 2006;67:303–310.
   PubMed Web of Science ®Google Scholar
• Abdou AM, Gao X, Cozen W, et al. Human leukocyte antigen (HLA) A1-B8-DR3 (8.1) haplotype, tumor necrosis factor (TNF) G-308A, and risk of non-Hodgkin lymphoma. Leukemia. 2010;24:1055–1058.
   PubMed Web of Science ®Google Scholar
• Lu Y, Abdou AM, Cerhan JR, et al. Human leukocyte antigen class I and II alleles and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Sci World J. 2011;11:2062–2070.
   Google Scholar
• Akers NK, Curry JD, Conde L, et al. Association of HLA-DQB1 alleles with risk of follicular lymphoma. Leuk Lymphoma. 2011;52:53–58.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Bracci PM, Nieters A, et al. Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol. 2010;171:267–276.
   PubMed Web of Science ®Google Scholar
• Rothman N, Skibola CF, Wang SS, et al. Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol. 2006;7:27–38.
   PubMed Web of Science ®Google Scholar
• Wang SS, Abdou AM, Morton LM, et al. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology. Blood. 2010;115:4820–4823.
   PubMed Web of Science ®Google Scholar
• Gragert L, Fingerson S, Albrecht M, et al. Fine-mapping of HLA associations with chronic lymphocytic leukemia in US populations. Blood. 2014;124:2657–2665.
   PubMed Web of Science ®Google Scholar
• El Ansary MM, Mohammed LA, Hassan TH, et al. Human leukocyte antigen-DRB1 polymorphism in childhood acute lymphoblastic leukemia. Mol Clin Oncol. 2015;3:425–429.
   PubMed Web of Science ®Google Scholar
• Speedy HE, Di Bernardo MC, Sava GP, et al. A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia. Nat Genet. 2014;46:56–60.
   PubMed Web of Science ®Google Scholar
• Taylor GM, Hussain A, Verhage V, et al. Strong association of the HLA-DP6 supertype with childhood leukaemia is due to a single allele, DPB1*0601. Leukemia. 2009;23:863–869.
   PubMed Web of Science ®Google Scholar
• Orouji E, Tavakkol Afshari J, Badiee Z, et al. Association between HLA-DQB1 gene and patients with acute lymphoblastic leukemia (ALL). Int J Hematol. 2012;95:551–555.
   PubMed Web of Science ®Google Scholar
• Naugler C, Liwski R. Human leukocyte antigen class I alleles and the risk of chronic myelogenous leukemia: a meta-analysis. Leuk Lymphoma. 2010;51:1288–1292.
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Berndt SI, Vijai J, et al. Genome-wide association study identifies multiple susceptibility loci for diffuse large B cell lymphoma. Nat Genet. 2014;46:1233–1238.
   PubMed Web of Science ®Google Scholar
• Bassig BA, Cerhan JR, Au WY, et al. Genetic susceptibility to diffuse large B‐cell lymphoma in a pooled study of three Eastern Asian populations. Eur J Haematol. 2015;95:442–448.
   PubMed Web of Science ®Google Scholar
• Smedby KE, Foo JN, Skibola CF, et al. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 2011;7:e1001378.
   PubMed Web of Science ®Google Scholar
• Conde L, Halperin E, Akers NK, et al. Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010;42:661–664.
   PubMed Web of Science ®Google Scholar
• Skibola CF, Berndt SI, Vijai J, et al. Genome-wide association study identifies five susceptibility loci for follicular lymphoma outside the HLA region. Am J Hum Genet. 2014;95:462–471.
   PubMed Web of Science ®Google Scholar
• Berndt SI, Skibola CF, Joseph V, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45:868–876.
   PubMed Web of Science ®Google Scholar
• Slager SL, Goldin LR, Strom SS, et al. Genetic susceptibility variants for chronic lymphocytic leukemia. Cancer Epidemiol Biomarkers Prev. 2010;19:1098–1102.
   PubMed Web of Science ®Google Scholar
• Slager SL, Camp NJ, Conde L, et al. Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes. Br J Haematol. 2012;159:572–576.
   PubMed Web of Science ®Google Scholar
• Vijai J, Wang Z, Berndt SI, et al. A genome-wide association study of marginal zone lymphoma shows association to the HLA region. Nat Commun. 2015;6:5751.
   PubMed Web of Science ®Google Scholar
• Cerhan JR, Fredericksen ZS, Wang AH, et al. Design and validity of a clinic-based case-control study on the molecular epidemiology of lymphoma. Int J Mol Epidemiol Genet. 2011;2:95–113.
   PubMedGoogle Scholar
• Holly EA, Gautam M, Bracci PM. Comparison of interviewed and non-interviewed non-Hodgkin's lymphoma (NHL) patients in the San Francisco Bay Area. Ann Epidemiol. 2002;12:419–425.
   PubMed Web of Science ®Google Scholar
• Hu ZH, Connett JE, Yuan JM, et al. Role of survivor bias in pancreatic cancer case-control studies. Ann Epidemiol. 2016;26:50–56.
   PubMed Web of Science ®Google Scholar
• Morton LM, Turner JJ, Cerhan JR, et al. Proposed classification of lymphoid neoplasms for epidemiologic research from the Pathology Working Group of the International Lymphoma Epidemiology Consortium (InterLymph). Blood. 2007;110:695–708.
   PubMed Web of Science ®Google Scholar
• Turner JJ, Morton LM, Linet MS, et al. InterLymph hierarchical classification of lymphoid neoplasms for epidemiologic research based on the WHO classification (2008): update and future directions. Blood. 2010;116:e90–e98.
   PubMed Web of Science ®Google Scholar
• González-Galarza Faviel F, Takeshita Louise YC, Santos Eduardo JM, et al. Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations. Nucleic Acids Res. 2015;43:D784–D788.
   PubMed Web of Science ®Google Scholar
• Gourraud P-A, Lamiraux P, El-Kadhi N, et al. Inferred HLA haplotype information for donors from hematopoietic stem cells donor registries. Hum Immunol. 2005;66:563–570.
   PubMed Web of Science ®Google Scholar
• Madbouly A, Gragert L, Freeman J, et al. Validation of statistical imputation of allele-level multilocus phased genotypes from ambiguous HLA assignments. Tissue Antigens. 2014;84:285–292.
   PubMedGoogle Scholar
• Paunić V, Gragert L, Madbouly A, et al. Measuring ambiguity in HLA typing methods. PLoS One. 2012;7:e43585.
   PubMed Web of Science ®Google Scholar
• Gragert L, Madbouly A, Freeman J, et al. Six-locus high resolution HLA haplotype frequencies derived from mixed-resolution DNA typing for the entire US donor registry. Hum Immunol. 2013;74:1313–1320.
   PubMed Web of Science ®Google Scholar
• Klein SL, Jedlicka A, Pekosz A. The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis. 2010;10:338–349.
   PubMed Web of Science ®Google Scholar
• Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc B (Methodol). 1995;57:289–300.
   Web of Science ®Google Scholar
• Skibola CF, Akers NK, Conde L, et al. Multi-locus HLA class I and II allele and haplotype associations with follicular lymphoma. Tissue Antigens. 2012;79:279–286.
   PubMedGoogle Scholar
• Smigoc Schweiger D, Mendez A, Kunilo Jamnik S, et al. High-risk genotypes HLA-DR3-DQ2/DR3-DQ2 and DR3-DQ2/DR4-DQ8 in co-occurrence of type 1 diabetes and celiac disease. Autoimmunity. 2016;49:240–247.
   PubMed Web of Science ®Google Scholar
• Klitz W, Gragert L, Maiers M, et al. Genetic differentiation of Jewish populations. Tissue Antigens. 2010;76:442–458.
   PubMedGoogle Scholar
• Manor S, Halagan M, Shriki N, et al. High-resolution HLA A ∼ B∼DRB1 haplotype frequencies from the Ezer Mizion Bone Marrow Donor Registry in Israel. Hum Immunol. 2016;77:1114–1119.
   PubMed Web of Science ®Google Scholar
• Guðjónsson JE, Valdimarsson H, Kárason A, et al. HLA-Cw6-positive and HLA-Cw6-negative patients with psoriasis vulgaris have distinct clinical features. J Investig Dermatol. 2002;118:362–365.
   PubMed Web of Science ®Google Scholar
• Noble JA. Immunogenetics of type 1 diabetes: a comprehensive review. J Autoimmun. 2015;64:101–112.
   PubMed Web of Science ®Google Scholar
• Wang SS, Carrington M, Berndt SI, et al. HLA class I and II diversity contributes to the etiologic heterogeneity of non-Hodgkin lymphoma subtypes. Cancer Res. 2018;78:4086–4096.
   PubMed Web of Science ®Google Scholar
• Wang SS, Hartge P. Etiology and epidemiology of non-Hodgkin lymphoma. In: Armitage JO, Mauch PM, Harris NL, et al., editors. Non-Hodgkin lymphomas. 2nd ed. Philadelphia (PA): Lippincott, Williams and Wilkins; 2010. p. 64–82.
   Google Scholar
• Blackwell JM, Jamieson SE, Burgner D. HLA and infectious diseases. Clin Microbiol Rev. 2009;22:370–385.
   PubMed Web of Science ®Google Scholar
• Thio CL, Thomas DL, Karacki P, et al. Comprehensive analysis of class I and class II HLA antigens and chronic hepatitis B virus infection. J Virol. 2003;77:12083–12087.
   PubMed Web of Science ®Google Scholar
• De La Concha EG, Fernandez-Arquero M, Martinez A, et al. HLA class II homozygosity confers susceptibility to common variable immunodeficiency (CVID). Clin Exp Immunol. 1999;116:516–520.
   PubMed Web of Science ®Google Scholar
• Arrieta-Bolaños E, Madrigal JA, Shaw BE. Human leukocyte antigen profiles of Latin American populations: differential admixture and its potential impact on hematopoietic stem cell transplantation. Bone Marrow Res. 2012;2012:13.
   Google Scholar
• Center for International Blood and Marrow Transplant, a contractor for the C.W. Bill Young Cell Transplantation Program operated through the U.S. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau. U.S. Transplant Data by Center Report, NHL – Non-Hodgkin Lymphoma, Number of Transplants Reported in 2016. U.S. Transplant Data by Center Report. Last Updated: May 17, 2017; [cited 9 March 2018]. Available from: https://bloodcell.transplant.hrsa.gov/research/transplant_data/us_tx_data/data_by_center/center.aspx
   Google Scholar